- Home
- TELA vs RADX Comparison
TELA vs RADX Comparison
Compare TELA & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- RADX
- Stock Information
- Founded
- TELA 2012
- RADX 2021
- Country
- TELA United States
- RADX Australia
- Employees
- TELA N/A
- RADX N/A
- Industry
- TELA Medical/Dental Instruments
- RADX
- Sector
- TELA Health Care
- RADX
- Exchange
- TELA Nasdaq
- RADX NYSE
- Market Cap
- TELA 36.4M
- RADX 32.5M
- IPO Year
- TELA 2019
- RADX N/A
- Fundamental
- Price
- TELA $2.04
- RADX $4.00
- Analyst Decision
- TELA Strong Buy
- RADX Strong Buy
- Analyst Count
- TELA 4
- RADX 2
- Target Price
- TELA $6.00
- RADX $13.50
- AVG Volume (30 Days)
- TELA 97.2K
- RADX 23.0K
- Earning Date
- TELA 08-11-2025
- RADX 02-26-2025
- Dividend Yield
- TELA N/A
- RADX N/A
- EPS Growth
- TELA N/A
- RADX N/A
- EPS
- TELA N/A
- RADX N/A
- Revenue
- TELA $71,217,000.00
- RADX $204,609.00
- Revenue This Year
- TELA $26.67
- RADX N/A
- Revenue Next Year
- TELA $22.63
- RADX N/A
- P/E Ratio
- TELA N/A
- RADX N/A
- Revenue Growth
- TELA 12.78
- RADX N/A
- 52 Week Low
- TELA $0.86
- RADX $3.50
- 52 Week High
- TELA $5.18
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- TELA 65.71
- RADX N/A
- Support Level
- TELA $1.85
- RADX N/A
- Resistance Level
- TELA $1.94
- RADX N/A
- Average True Range (ATR)
- TELA 0.19
- RADX 0.00
- MACD
- TELA 0.00
- RADX 0.00
- Stochastic Oscillator
- TELA 91.80
- RADX 0.00
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.